KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrana Health (ASTH) Cash & Equivalents: 2009-2024

Historic Cash & Equivalents for Astrana Health (ASTH) over the last 16 years, with FY2024 value amounting to $288.5 million.

  • Astrana Health's Cash & Equivalents rose 3282.61% to $462.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $462.2 million, marking a year-over-year increase of 3282.61%. This contributed to the annual value of $288.5 million for FY2024, which is 182.16% down from last year.
  • Latest data reveals that Astrana Health reported Cash & Equivalents of $288.5 million as of FY2024, which was down 182.16% from $293.8 million recorded in FY2023.
  • In the past 5 years, Astrana Health's Cash & Equivalents registered a high of $293.8 million during FY2023, and its lowest value of $193.5 million during FY2020.
  • In the last 5 years, Astrana Health's Cash & Equivalents had a median value of $288.0 million in 2022 and averaged $259.4 million.
  • In the last 5 years, Astrana Health's Cash & Equivalents skyrocketed by 8749.09% in 2020 and then plummeted by 182.16% in 2024.
  • Astrana Health's Cash & Equivalents (Annual) stood at $193.5 million in 2020, then grew by 20.48% to $233.1 million in 2021, then rose by 23.57% to $288.0 million in 2022, then increased by 2.01% to $293.8 million in 2023, then fell by 1.82% to $288.5 million in 2024.
  • Its Cash & Equivalents stands at $288.5 million for FY2024, versus $293.8 million for FY2023 and $288.0 million for FY2022.